Fitzgerald Kevin Joseph - Insider Non-Derivative Transactions at ALNYLAM PHARMACEUTICALS, INC. (ALNY) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 12, 2024, Fitzgerald Kevin Joseph's relationship to ALNYLAM PHARMACEUTICALS, INC. (ALNY) is Officer (CSO & EVP, Head of Research), and currently has 34,906 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ALNY insiders.

Data Source: SEC.
Fitzgerald Kevin Joseph - Insider Non-Derivative Transactions of ALNY Common Stock
Fitzgerald Kevin Joseph - Insider Non-Derivative Transactions at ALNY
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 13, 2024 Sell -- (Common Stock) 135 274.65 12881
Aug 13, 2024 Sell -- (Common Stock) 1158 273.73 13016
Aug 13, 2024 Sell -- (Common Stock) 3913 272.43 14174
Aug 13, 2024 Sell -- (Common Stock) 5736 271.32 18087
Aug 13, 2024 M -- (Common Stock) 6667 97.72 20848
Aug 13, 2024 Sell -- (Common Stock) 9662 270.17 23823
Aug 13, 2024 Sell -- (Common Stock) 1421 268.66 33485
Aug 13, 2024 M -- (Common Stock) 14058 85 34906
Jun 26, 2024 Sell -- (Common Stock) 125 235.19 14181
Jun 26, 2024 Sell -- (Common Stock) 138 234.66 14306
Jun 26, 2024 Sell -- (Common Stock) 86 233.53 14444
Jun 26, 2024 Sell -- (Common Stock) 161 232.54 14530
Jun 26, 2024 Sell -- (Common Stock) 74 231.59 14691
Jun 26, 2024 Sell -- (Common Stock) 227 229.93 14765
Jun 26, 2024 Sell -- (Common Stock) 198 229.06 14992
Jun 26, 2024 Sell -- (Common Stock) 96 228.3 15190
Jun 26, 2024 Sell -- (Common Stock) 26 226.82 15286
Jun 26, 2024 Sell -- (Common Stock) 13 225.55 15312
Jun 26, 2024 Sell -- (Common Stock) 9 224.17 15325
Jun 26, 2024 Sell -- (Common Stock) 45 221.71 15334
Jun 25, 2024 Acquisition -- (Common Stock) 2498 0 15379